Staar Surgical Co.
STAA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.32B
Close$
$2.17
91.2% downside
Current Fair Value
91.2% downsideOvervalued by 91.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.32 Billion |
|---|---|
| Enterprise Value | $1.25 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.62 |
| Beta | 1.23 |
| Outstanding Shares | 49,908,000 |
Return
| Return on Equity | -2253.23% |
|---|---|
| Return on Assets | -1759.98% |
| Return on Invested Capital | -1.87% |
Valuation & Multiples
| P/E Ratio | -62.95 |
|---|---|
| PEG | 57.44 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 3.53 |
| Enterprise Value to Revenue | 0.01 |
| Enterprise Value to EBIT | -171.34 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$78.72 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$0.20
Average shareholder expectationRevenue Estimate
$83.10 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 114.44% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.40%▼ 107.36% |
|---|---|
| Total Invested | $20.01M▼ 98.02% |
| Investors Holding | 18▼ 178.00% |
ESG Score
No data
About Staar Surgical Co.
CEO: Caren Mason